Clinical Research in Hematology Division

Clinical trials involving novel therapeutic agents, including targeted therapies and immunotherapies, are a major focus of the Hematology Division. Our clinical investigators are active in the design and execution of clinical trials that range from early to late phase studies designed to assess efficacy, characterize biological effects, and accelerate approval of the most promising agents for treatment of hematologic disorders. Our investigators are also actively involved in translational research investigating molecular genetics and pathophysiology in hematologic diseases.

Trials listed by Faculty

Trials listed by Disease

For Inquiries Please Contact

General Questions

(650) 498-7425

clinicaltrials@med.stanford.edu

Cancer Clinical Trials:

(650) 498-7061